Watchlist Price Alert

Quest Diagnostics (DGX)

NYSE: DGX · Real-Time Price · USD

176.66

-2.67 (-1.49%)

At close: Jul 02, 2025, 3:59 PM

177.00

0.19%

Pre-market: Jul 03, 2025, 06:01 AM EDT

Quest Diagnostics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	549M	686M	315M	872M	1.16B	1.19B	135M	137M	359M
Short-Term Investments	n/a	n/a	n/a	44M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	123M	135M	132M	141M	521M	482M	436M	462M	443M
Other Long-Term Assets	255M	198M	144M	163M	176M	160M	119M	132M	116M
Receivables	1.3B	1.21B	1.2B	1.44B	1.52B	1.06B	1.01B	924M	926M
Inventory	188M	190M	192M	208M	223M	123M	99M	95M	82M
Other Current Assets	n/a	286M	196M	n/a	n/a	n/a	n/a	n/a	9M
Total Current Assets	2.39B	2.37B	1.9B	2.74B	3.06B	2.49B	1.39B	1.31B	1.53B
Property-Plant & Equipment	2.76B	2.42B	2.35B	2.3B	2.23B	1.97B	1.29B	1.15B	1.03B
Goodwill & Intangibles	10.62B	8.9B	8.31B	8.26B	8.04B	7.74B	7.77B	7.45B	6.95B
Total Long-Term Assets	13.76B	11.65B	10.94B	10.87B	10.97B	10.35B	9.61B	9.2B	8.57B
Total Assets	16.15B	14.02B	12.84B	13.61B	14.03B	12.84B	11B	10.5B	10.1B
Account Payables	287M	378M	324M	357M	446M	263M	222M	224M	231M
Deferred Revenue	n/a	516M	n/a	n/a	n/a	n/a	17M	80M	3M
Short-Term Debt	764M	303M	94M	118M	155M	892M	562M	107M	36M
Other Current Liabilities	856M	600M	97M	79M	76M	78M	85M	68M	34M
Total Current Liabilities	2.17B	1.81B	1.55B	1.75B	1.78B	1.99B	1.49B	1.06B	981M
Long-Term Debt	5.62B	4.41B	3.98B	4.01B	4.01B	3.97B	3.52B	3.75B	3.82B
Other Long-Term Liabilities	938M	876M	812M	792M	847M	711M	652M	663M	566M
Total Long-Term Liabilities	7.09B	5.79B	5.28B	5.3B	5.36B	5.09B	4.17B	4.41B	4.38B
Total Liabilities	9.26B	7.6B	6.83B	7.05B	7.13B	7.08B	5.66B	5.47B	5.36B
Total Debt	7.09B	5.5B	4.62B	4.66B	4.66B	5.33B	3.89B	3.78B	3.73B
Common Stock	2M	2M	2M	2M	2M	2M	2M	2M	2M
Retained Earnings	9.36B	8.82B	8.29B	7.65B	9.3B	8.17B	7.6B	7.14B	6.61B
Comprehensive Income	-88M	-14M	-21M	-14M	-21M	-39M	-59M	-48M	-72M
Shareholders Equity	6.78B	6.31B	5.89B	6.44B	6.76B	5.64B	5.22B	4.92B	4.63B
Total Investments	123M	135M	132M	141M	521M	482M	436M	462M	443M